Contribution of the Epstein-Barr Virus to the Pathogenesis of Hodgkin Lymphoma (Q38596350)

4 September 2017

title

Contribution of the Epstein-Barr Virus to the Pathogenesis of Hodgkin Lymphoma (English)

1 reference

4 September 2017

1 reference

1 reference

4 September 2017

Paul Murray

1 reference

4 September 2017

publication date

1 January 2015

1 reference

Current Topics in Microbiology and Immunology

4 September 2017

published in

1 reference

4 September 2017

volume

390

1 reference

4 September 2017

issue

Pt 1

1 reference

4 September 2017

page(s)

287-313

1 reference

Expression of functional interleukin-3 receptors on Hodgkin and Reed-Sternberg cells

4 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Expression of CCR5 receptors on Reed-Sternberg cells and Hodgkin lymphoma cell lines: involvement of CCL5/Rantes in tumor cell growth and microenvironmental interactions.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The classical Hodgkin's lymphoma microenvironment and its role in promoting tumour growth and immune escape.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: a quantitative tissue microarray study in a large retrospective cohort of 267 patients.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

An auto-regulatory loop for EBV LMP2A involves activation of Notch

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The H3K27me3 demethylase, KDM6B, is induced by Epstein-Barr virus and over-expressed in Hodgkin's Lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

PD-1 blockade with nivolumab in relapsed or refractory Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Epstein-Barr virus and Hodgkin's disease: further evidence for the three disease hypothesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Gains of 2p involving the REL locus correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Expression of the Epstein-Barr virus-encoded Epstein-Barr virus nuclear antigen 1 in Hodgkin's lymphoma cells mediates Up-regulation of CCL20 and the migration of regulatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Transformation of BCR-deficient germinal-center B cells by EBV supports a major role of the virus in the pathogenesis of Hodgkin and posttransplantation lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Hodgkin lymphoma and immunodeficiency in persons with HIV/AIDS

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

CC chemokines and the receptors CCR3 and CCR5 are differentially expressed in the nonneoplastic leukocytic infiltrates of Hodgkin disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Mutations in the IkBa gene in Hodgkin's disease suggest a tumour suppressor role for IkappaBalpha.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The EBV oncogene LMP1 protects lymphoma cells from cell death through the collagen-mediated activation of DDR1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Epstein-Barr virus LMP2A drives B cell development and survival in the absence of normal B cell receptor signals

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Functional coexpression of Interleukin (IL)-7 and its receptor (IL-7R) on Hodgkin and Reed-Sternberg cells: Involvement of IL-7 in tumor cell growth and microenvironmental interactions of Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Epstein-Barr virus infection in vitro can rescue germinal center B cells with inactivated immunoglobulin genes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Hodgkin lymphoma cells express TACI and BCMA receptors and generate survival and proliferation signals in response to BAFF and APRIL

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Perinatal and family risk factors for Hodgkin lymphoma in childhood through young adulthood

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Perinatal and family risk factors for non-Hodgkin lymphoma in early life: a Swedish national cohort study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Epstein-Barr virus and Hodgkin's disease: transcriptional analysis of virus latency in the malignant cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Expression of the cellular FLICE-inhibitory protein (c-FLIP) protects Hodgkin's lymphoma cells from autonomous Fas-mediated death

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Bmi-1 is induced by the Epstein-Barr virus oncogene LMP1 and regulates the expression of viral target genes in Hodgkin lymphoma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Activation of the p38 mitogen-activated protein kinase pathway by Epstein-Barr virus-encoded latent membrane protein 1 coregulates interleukin-6 and interleukin-8 production

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Inactivating I kappa B epsilon mutations in Hodgkin/Reed-Sternberg cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The molecular pathogenesis of Hodgkin lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Expression of CCL5/RANTES by Hodgkin and Reed-Sternberg cells and its possible role in the recruitment of mast cells into lymphomatous tissue

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Functional expression of receptor activator of nuclear factor kappaB in Hodgkin disease cell lines.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

South Asian ethnicity and material deprivation increase the risk of Epstein-Barr virus infection in childhood Hodgkin's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Down-regulation of the TGF-beta target gene, PTPRK, by the Epstein-Barr virus encoded EBNA1 contributes to the growth and survival of Hodgkin lymphoma cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Contributions of Epstein-Barr nuclear antigen 1 (EBNA1) to cell immortalization and survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Latent membrane protein 2A inhibits transforming growth factor-beta 1-induced apoptosis through the phosphatidylinositol 3-kinase/Akt pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classic Hodgkin lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Clinical characteristics, incidence, and risk factors of HIV-related Hodgkin lymphoma in the era of combination antiretroviral therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Recurrent somatic mutations of PTPN1 in primary mediastinal B cell lymphoma and Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Expression of CCL28 by Reed-Sternberg cells defines a major subtype of classical Hodgkin's disease with frequent infiltration of eosinophils and/or plasma cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Nuclear factor kappaB-dependent gene expression profiling of Hodgkin's disease tumor cells, pathogenetic significance, and link to constitutive signal transducer and activator of transcription 5a activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Risk of Hodgkin's Disease and Other Cancers After Infectious Mononucleosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Infectious Mononucleosis, Childhood Social Environment, and Risk of Hodgkin Lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

HLA-A alleles and infectious mononucleosis suggest a critical role for cytotoxic T-cell response in EBV-related Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Protein profiling with Epstein-Barr nuclear antigen-1 reveals an interaction with the herpesvirus-associated ubiquitin-specific protease HAUSP/USP7.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Ligand-independent signaling by overexpressed CD30 drives NF-kappaB activation in Hodgkin-Reed-Sternberg cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

EBV may be expressed in the LP cells of nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) in both children and adults

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin lymphoma fosters immune privilege

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Hodgkin's lymphoma cell lines are characterized by frequent aberrations on chromosomes 2p and 9p including REL and JAK2.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Loss of PU.1 expression is associated with defective immunoglobulin transcription in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Clonal deleterious mutations in the IkappaBalpha gene in the malignant cells in Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The AP1-dependent secretion of galectin-1 by Reed Sternberg cells fosters immune privilege in classical Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Tumor-infiltrating macrophages correlate with adverse prognosis and Epstein-Barr virus status in classical Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Epstein-Barr virus latent membrane protein-1 triggers AP-1 activity via the c-Jun N-terminal kinase cascade

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

IL-10 can induce the expression of EBV-encoded latent membrane protein-1 (LMP-1) in the absence of EBNA-2 in B lymphocytes and in Burkitt lymphoma- and NK lymphoma-derived cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

IL-21 imposes a type II EBV gene expression on type III and type I B cells by the repression of C- and activation of LMP-1-promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

STAT6 signaling pathway activated by the cytokines IL-4 and IL-13 induces expression of the Epstein-Barr virus–encoded protein LMP-1 in absence of EBNA-2: implications for the type II EBV latent gene expression in Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

STAT3 is constitutively activated in Hodgkin cell lines

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The biology of Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Hodgkin disease: Hodgkin and Reed-Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Identification of Hodgkin and Reed-Sternberg cell-specific genes by gene expression profiling

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Genetic associations in classical hodgkin lymphoma: a systematic review and insights into susceptibility mechanisms

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Mutations of NFKBIA, encoding IkappaB alpha, are a recurrent finding in classical Hodgkin lymphoma but are not a unifying feature of non-EBV-associated cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

CD40 and its viral mimic, LMP1: similar means to different ends

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Latent membrane protein 1 of EBV activates phosphatidylinositol 3-kinase to induce production of IL-10.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Epigenetic and transcriptional changes which follow Epstein-Barr virus infection of germinal center B cells and their relevance to the pathogenesis of Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Arginine Methyltransferases Are Regulated by Epstein-Barr Virus in B Cells and Are Differentially Expressed in Hodgkin's Lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Elevated antibody titers to Epstein-Barr virus in Hodgkin's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Transcriptional regulatory cascades controlling plasma cell differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The mutational landscape of Hodgkin lymphoma cell lines determined by whole-exome sequencing

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The microenvironment in classical Hodgkin lymphoma: an actively shaped and essential tumor component.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Epstein-Barr Virus nuclear antigen 1 (EBNA1) confers resistance to apoptosis in EBV-positive B-lymphoma cells through up-regulation of survivin

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Rescue of "crippled" germinal center B cells from apoptosis by Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The relationships between Epstein-Barr virus latent membrane protein 1 and regulatory T cells in Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Recurrent involvement of the REL and BCL11A loci in classical Hodgkin lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Chromosomal rearrangements involving the BCL3 locus are recurrent in classical Hodgkin and peripheral T-cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Elevated NF-kappaB p50 complex formation and Bcl-3 expression in classical Hodgkin, anaplastic large-cell, and other peripheral T-cell lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Increased programmed death-1+ tumor-infiltrating lymphocytes in classical Hodgkin lymphoma substantiate reduced overall survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Immunohistochemical demonstration of the Epstein-Barr virus-encoded latent membrane protein in paraffin sections of Hodgkin's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Rare occurrence of classical Hodgkin's disease as a T cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

HLA-A*02 is associated with a reduced risk and HLA-A*01 with an increased risk of developing EBV+ Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The transcriptional regulation of B cell lineage commitment.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Genetic lesions of the TRAF3 and MAP3K14 genes in classical Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Functional delivery of viral miRNAs via exosomes

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Epstein-Barr virus (EBV) LMP2A alters normal transcriptional regulation following B-cell receptor activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Epstein-Barr Virus (EBV) LMP2A induces alterations in gene transcription similar to those observed in Reed-Sternberg cells of Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Hodgkin lymphoma requires stabilized NIK and constitutive RelB expression for survival

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The aberrant coexpression of several receptor tyrosine kinases is largely restricted to EBV-negative cases of classical Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Notch is an essential upstream regulator of NF-κB and is relevant for survival of Hodgkin and Reed-Sternberg cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The role of cytokines in classical Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Interleukin 13 and interleukin 13 receptor are frequently expressed by Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Inhibition of EBF function by active Notch signaling reveals a novel regulatory pathway in early B-cell development

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Gene expression profiling of microdissected Hodgkin Reed-Sternberg cells correlates with treatment outcome in classical Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Down-regulation of BOB.1/OBF.1 and Oct2 in classical Hodgkin disease but not in lymphocyte predominant Hodgkin disease correlates with immunoglobulin transcription

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Defective octamer-dependent transcription is responsible for silenced immunoglobulin transcription in Reed-Sternberg cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The transcription factor PU.1, necessary for B-cell development is expressed in lymphocyte predominance, but not classical Hodgkin's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Refined prognostic role of CD68-positive tumor macrophages in the context of the cellular micromilieu of classical Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Suppression of the LMP2A target gene, EGR-1, protects Hodgkin's lymphoma cells from entry to the EBV lytic cycle.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Down-regulation of BLIMP1α by the EBV oncogene, LMP-1, disrupts the plasma cell differentiation program and prevents viral replication in B cells: implications for the pathogenesis of EBV-associated B-cell lymphomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

BLIMP1α, the master regulator of plasma cell differentiation is a tumor supressor gene in B cell lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Hypomethylation and Over-Expression of the Beta Isoform of BLIMP1 is Induced by Epstein-Barr Virus Infection of B Cells; Potential Implications for the Pathogenesis of EBV-Associated Lymphomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Mutations of the tumor suppressor gene SOCS-1 in classical Hodgkin lymphoma are frequent and associated with nuclear phospho-STAT5 accumulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

PD-1-PD-1 ligand interaction contributes to immunosuppressive microenvironment of Hodgkin lymphoma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

Epstein-Barr virus latent genes in tumour cells of Hodgkin's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1007%2F978-3-319-22822-8_12

10.1007/978-3-319-22822-8_12

31 March 2020

Identifiers

DOI

1 reference

4 September 2017

1 reference